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ABSTRACT
Clostridium difficile (C. difficile) is the main pathogen causing antibiotics associated diarrhea and colitis. 
This bacterium increases with hospitalization with incidence of 20-60 cases per 100,000 patients/day. C. difficile 
is gram positive bacilli which produce toxins in 2,700 cases in every 100,000 exposures to particular antibiotics, 
such as clindamycin, cephalosporin, and ampicillin. These antibiotics disrupt the intestinal normal flora and 
predispose to colonization of C. difficile. 
This case described a 53-year old male patient with squamous cell carcinoma in his left ear who came to 
Department of Internal Medicine, Cipto Mangunkusumo Hospital, with the complain of diarrhea since two weeks 
after one month hospitalization in Department of Ear, Nose, and Throat. The characteristics of the diarrhea were 
10 times per day ± 100 mL, watery consistency, green yellowish in color, and no blood in the feces. Additionally, 
the patient also complained of pain in all parts of his stomach, especially in the epigastric area. Earlier, patient 
was given ceftazidime for 30 days of hospitalization. The serology examination of C. difficile in the feces showed 
positive result (titer = 0.790 and control = 0.190). During the colonoscopy examination, pancolitis was found and 
the pathologic anatomy result was found appropriate for infective colitis. Thereafter, antibiotic administration 
was ceased and metronidazole was administered intravenously three times a day. The diarrhea stopped after 
seven days and the patient was discharged.
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ABSTRAK
Clostridium difficile (C. difficile) adalah patogen utama yang menyebabkan diare dan kolitis akibat antibiotika. 
Bakteri ini meningkat dalam perawatan di rumah sakit dengan insiden 20-60 kasus per 100,000 pasien/hari. 
C. difficile adalah basil gram positif yang menghasilkan toksin pada 2,700 kasus dalam 100,000 paparan 
antibiotika seperti klindamisin, sefalosporin dan ampisilin. Antibiotika tersebut menggangu flora normal di 
usus dan merupakan predisposisi kolonisasi C. difficile. 
Pada kasus ini dilaporkan seorang laki-laki, 53 tahun dengan karsinoma sel skuamosa di telinga kirinya 
yang datang ke ruang perawatan Departemen Ilmu Penyakit Dalam Rumah Sakit Cipto Mangunkusumo dengan 
keluhan diare sejak 2 minggu setelah perawatan selama satu bulan di Departemen Telinga, Hidung, Tenggorokan. 
Karakteristik diare sekitar 10 kali per hari ± 100 mL dengan konsistensi cair, warna hijau kekuningan, tidak 
terdapat darah. Selain itu pasien juga mengeluh nyeri di seluruh perutnya khususnya di daerah epigastrium. 
Sebelumnya pasien mendapat ceftazidim selama 30 hari selama perawatan. Pemeriksaan serologi toksin 
C. difficile pada feses memperlihatkan hasil positif (titer = 0,790; kontrol = 0,190). Dari hasil pemeriksaan 
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kolonoskopi ditemukan pankolitis dan pemeriksaan patologi anatomi ditemukan kolitis infektif. Pemberian 
antibiotika dihentikan kemudian diberikan metronidazole 500 mg intra vena tiga kali sehari. Diare berhenti 
setelah tujuh hari kemudian dan pasien dapat dipulangkan. 
Kata kunci: Clostridium difficille, diare nosokomial, keganasan
INTRODUCTION
The term Clostridium difficile (C. difficile) 
diarrhea is used in diarrhea caused by infection of its 
own organism. This nosocomial infection has been 
noted to cause outbreak of C. difficile diarrhea in 
the hospitals, with incidence rate of 20-60 cases in 
every 100.000 patients/day and this number tends 
to increase. Similarly, 3 million cases of C. difficile 
diarrhea and colitis is reported every year in the United 
States.1 In the hospital, infected and colonized patients 
and the contaminated environment are associated with 
the source of C. difficile infection.2,3
C. difficile is gram positive bacillus which is 
a colony in human intestine found in 1-3% healthy 
adult, approximately 20% of patients who received 
antibiotic, and 50% of neonates. Subsequently, 
a part of this colony will cause symptoms after 
the intestinal normal flora is changed and dominated 
by the pathogen.4,5 The prevalence of toxin producing 
C. difficile is around 2,700 cases per 100,000 antibiotic 
exposures. Antibiotics often cause C. difficile diarrhea 
are clindamycin, cephalosporin, and penicillin. 
The use of these antibiotics will disrupt intestinal 
normal flora and will also lead to the predisposition 
of C. difficile colonization, commonly found in 
the health care centers.1
Currently, C. difficile has been an important 
nosocomial pathogen associated with morbidity and 
mortality. Upon exposure to C. difficile some patients 
become asymptomatic carrier, while others experienced 
diarrhea with a wide range of severity, from mild 
watery diarrhea to pseudomembranous colitis, 
which may eventually cause death.5 Some diagnostic 
modalities in C. difficile infection are intended to find 
the presence of toxin A or toxin B. These modalities 
include rapid enzymatic examination or polymerase 
chain reaction (PCR) method, to find the presence 
of toxin B of C. difficile in fecal specimen, fecal 
culture, latex agglutination test to find the presence 
of clostridium glutamate dehydrogenase protein, and 
endoscopy.5 In this case report would be reported 
a 53-year old male patient with squamous cell carcinoma 
in the left ear who experience nosocomial C. difficile 
diarrhea at the time further diagnostic examination and 
further treatment were to be performed.
CASE ILLUSTRATION
A 53-year-old male was hospitalized in Cipto 
Mangunkusumo Hospital with chief complain of 
watery stool for 15 days, after 30 days hospitalization 
in Ear, Nose, Throat (ENT) Department. Patient was 
diagnosed with stage IV squamous cell carcinoma 
in his left ear with intracranial infiltration and 
was intended to undergo chemoradiation therapy. 
During hospitalization, patient received ceftazidime 
3 x 1 g administered intravenously for treatment of 
lung and connective tissue infection. On day-15 of 
hospitalization, he had watery stool with frequency of 
more than 10 times per day ± 100 mL, yellow greenish 
in color, but with no mucus or blood. There was also 
complaining of aching all over his stomach, especially 
in the epigastric area. Patient was still able to pass 
gas (flatulence). Nausea was present, but no vomiting 
or fever. History of hypertension was present since 
the previous few years, however the medicine name 
could not be recalled. 
During visit to Department of Internal Medicine, 
patient was looking severely ill, fully alert, blood 
pressure 150/90 mmHg, heart rate 88 beats/minutes, 
respiratory rate 20 beats/minutes, and temperature 
of 36.8°C. Upon inspection, it was found that 
the patient had asymmetric face with no facies 
cholerica. Conjunctiva was not pale, sclera was not 
icteric, lagophtalmus, and esotrophia were present 
in the left eye. In the left ear, there was mass with 
solid consistency, immobile, with pus, but no blood. 
The right ear was within normal limits. Into his nose, 
nasogastric tube had been inserted, there was no 
septum deviation, mass, blood, or pus. There was no 
increase in the jugular venous pressure or enlargement 
of lymph nodes in the neck. Spider nevi were not 
found. The skin turgor was within normal limit. In 
the heart examination, impression of enlargement of 
the heart was conduded. No abnormality was found in 
lung examination. Abdominal examination revealed 
not distended abdomen, symmetric, supple, liver and 
spleen were not palpable, tymphani, positive shifting 
dullness, no pain on percussion of the costovertebrae 
angle, and normal bowel sound. Upon extremities 
examination, the acral was warm with pretibial and 
dorsum pedis edema. However, no cyanotic or palmar 
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erythema was found. Patient weighted 59 kg and 
measured height 166 cm.
In the laboratory examination during transfer 
to the Internal Medicine Department, it was found 
that hemoglobin 11.6 mg/dL, hematocryte 35.5%, 
leukocytes 8,800/µL, thrombocytes 256,000/µL, 
erythrocyte sedimentation rate 5 mm, differential 
count showed following results: eosinophil 0.1, 
basophil 0.2, neutrophil 12.1%, and monocytes 6.3%, 
aspartate aminotransferase (AST) 18 u/L, alanine 
aminotransferase (ALT) 24 u/L, albumin 2.1 g/dL, 
globulin 4.7 g/dL, cholinesterase 1654 u/L, ureum 
23 mg/dL, creatinine 0.6 mg/dL, random blood 
glucose 139 mg/dL, sodium 135 mEq/L, potassium 
2.04 mEq/L, and chloride 104 mEq/L. Fecal analysis 
revealed that the feces was yellow in color, watery 
consistency, full of leukocytes, erythrocytes 1-2, fat 
was present, and positive serological examination 
of C. difficile (titer = 0.790 and control = 0.190). 
Electrocardiography examination showed sinus 
rhythm, left axis deviation, QRS rate 98 bpm, 
P wave within normal limit, poor r-wave in V1 and V2, 
enlargement of the right and left ventricle. Posterior 
and anterior chest X-ray exhibit rough bronchovascular 
appearance and cardio-thoracic ratio > 50%.
Upon transfer to Department of Internal Medicine, 
patient’s problems were listed: C. difficile diarrhea, 
stage IV squamous cell carcinoma in the left ear with 
anemia, grade I hypertension, chronic liver disease, 
hypokalemia, hypoalbuminemia with ascites, and 
old myocardial infarct in the septum. The treatment 
given was Calbamin® infusion: Triofusin E® 1000 = 
1:1/12 hour and infusion of NaCl 0.9% 500 ml + KCL 
25 mEq/8 hours, liquid diet through nasogastric tube 
(NGT) 4 x 250 mL/day, Lacidofil® 3 x 1 tablet/day, 
metronidazole 3 x 500 mg ingtravenously, Plasbumin® 
50 mg 20% infusion 2 times, captopril 2 x 12.5 mg/
day orally dan ascardia 80 mg/day orally. On day-
38 of hospitalization, colonoscopy was performed 
and impression of pancolitis was established (Figure 
1). Biopsy of the lesion in the colon concluded the 
presence of infective colitis (Figure 2).
On day-40 of hospitalization, there was improvement 
in the frequency of diarrhea and the amount in every 
defecation. Besides, blood pressure began to be under 
control and hypokalemia and hypoalbuminemia 
were improved. On day-42 of hospitalization, patient 
was advised to undergo radiotherapy. Results of 
gastroenterology consultation recommended to stop 
the administration of metronidazole and substitute 
it with oral ofloxacine 400 mg/day for 7 days. On 
day-46 of hospitalization, patient refused to undergo 
chemoradiation and decided to continue his treatment 
in the outpatient ward. At that moment, diarrhea 
had stopped, no complain of nausea, stomachache, 
vomiting, and edema in the stomach and feet. 
Figure 1. Colonoscopy examination showed the presence of 
inflammation in almost all part of sigmoid colon, pars descenden, 
transversum, and pars ascenden with the conclusion of 
pancolitis
Figure 2. Specimen consisted of mucosal part of the colon 
tissue with conclusion no malignant cells were found in this 
specimen and impression of infective colitis
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The prognosis of this patient was dubia ad malam for 
ad vitam, ad fungtionam, and sanactionam.
DISCUSSION
A 53-year-old male patient came due to advanced 
stage of malignant tumor in his left ear with intracranial 
infiltration. Initially, patient was hospitalized in ENT 
Department in Cipto Mangunkusumo Hospital for 
diagnosis and treatment of the tumor in the left ear. 
During hospitalization, particularly on day-15 of 
hospitalization, he started to experience diarrhea.
Patient had watery stool with frequency of 
10 times ± 100 mL, feces was yellow greenish in 
color. Additionally, he also complained of nausea 
and stomachache. Upon transfer to the Internal 
Medicine Department, diarrhea had occurred for 
15 days, specifically 8 days before the transfer of 
hospitalization to the Internal Medicine ward and 
thus, was still considered as acute diarrhea.6 Patient 
experienced diarrhea with watery stool with no 
mucus or blood. He also complained of fever and 
stomachache. Fecal examination revealed the presence 
of a lot of leukocytes. These findings suggested 
the presence of inflammatory diarrhea, while in non-
inflammatory diarrhea, there would be no fever and 
leukocytes in the feces. One of the inflammatory 
diarrhea etiologies is C. difficile apart from Salmonella, 
Shigella, Campylobacter, Yersinia, invasive Escheria 
coli (E. coli), E. coli O157:H7, Staphylococcus 
aureus, and Vibrio parahemolyticus.7 If the diarrhea 
occurred during hospitalization and accompanied with 
stomachache, possibly this diarrhea was a nosocomial 
infection with C. difficile as the etiology.6-8
In the patient, there were 3 main risk factors which 
were associated with C. difficile, which included: 
exposure to antibiotic intravenous ceftazidime for 
15 days, more than 3 days of hospitalization, and patient 
had background of malignant tumor in the left ear in 
which there had been host immunity distruption.9,10 
Additionally, in this patient, there was administration 
of proton pump inhibitor (PPI). In accordance with 
the study performed by Dial et al, C. difficile diarrhea 
was significantly associated with the use of PPI with 
odds ratio 2.1 (CI = 1.2-3.5). Therefore, it could be 
summarized that in hospitalized patients who received 
PPI, the risk of C. difficile diarrhea was elevated.9-12
Cytotoxic examination of tissue culture to detect 
the presence of cytotoxin C. difficile, particularly 
toxin B in the fecal specimen was thought to be 
the gold standard diagnostic due to its high specificity 
(99-100%). The sensitivity of this examination is 
80-90%.10,11 Rapid enzymatic immune examination 
has been developed to detect toxin A or both toxin A 
and B from fecal specimen. Test kit is more sensitive 
to detect both toxins because this test could identify 
the disease caused by C. difficile strain. However, this 
test has low sensitivity (65-85%) and specificity (95-
100%) compared to cytotoxic examination.12,13 Lately, 
PCR method to detect toxin A or B C. difficile or both 
has been developed with better sensitivity (92-97%) 
and specificity (100%) compared with the cytotoxin 
examination of tissue culture.12-16
In this patient, immunologic Elisa examination 
to detect the presence of toxin A or B of C. difficile 
from fecal specimen was performed. Results of this 
examination was obtained in few hours. Though this 
test has low sensitivity (65-85%), it has quite high 
specificity (95-100%).10-14 The result of serologic 
examination in this patient was positive (titer = 0.790 
and control = 0.190). Due to the high specificity of this 
serologic examination, the value of positive results 
from this examination will have diagnostic value for 
C. difficile diarrhea.
According to the guidelines published by American 
College of Gastroenterology, the diagnosis of 
C. difficile diarrhea and colitis actually involves the 
presence of associated symptoms, such as diarrhea and 
at least one positive results from these examinations: 
endoscopy reveals the presence of pseudomembrane, 
fecal cytotoxic test shows the presence of toxin B, 
enzymatic immunologic examination from fecal 
specimen exhibits the presence of toxin A or toxin 
B or fecal culture of C. difficile.12,13,17 In this patient, 
there were symptoms associated with C. difficile 
diarrhea, particularly: watery and profuse diarrhea 
accompanied with pain in the stomach, nausea, and 
no appetite which appeared in more than 3 days of 
hospitalization. Furthermore, the patient had other few 
risk factors, such as frequent exposure of antibiotics 
specifically third generation cephalosporin, the use of 
PPI, and the underlying disease, malignant tumor in 
the ear. In the fecal serological Elisa examination to 
check the presence of C. difficile toxin, positive result 
was attained.
Initial step in the treatment of C. difficile diarrhea 
was to stop the administration of provoking agent, 
the most common is antibiotic if this action could be 
considered as appropriate medically. For mild illness, 
this action is usually adequate for total cure. For 
more severe illness, antibiotic therapy for C. difficile 
is usually required. Oral metronidazole therapy 250 
mg four times a day or 500 mg twice a day for 10-14 
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days is recommended as choice of first line therapy. 
As a second line therapy, oral vancomycin 125 mg 
four times a day for 10-14 days is recommended.17,18,19
However, it needs to be bear in mind that recently 
resistance case towards metronidazole in treatment 
of C. difficile colitis has been reported. In a study 
performed by Mushe et al, failure of metronidazole 
in treating patients with C. difficile colitis was found. 
Earlier study stated that nitazoxanide was as effective 
as metronidazole as an initial therapy for C. difficile 
colitis. Similarly, in the study carried out by Mushe 
et al, it was concluded that nitazoxanide appear as an 
effective therapy for C. difficile colitis patient who has 
failed to be treated with metronidazole.19,20,21
A meta-analysis suggested that probiotic could be 
used in preventing antibiotic associated diarrhea and 
Saccharomyces boulardii dan lactobacillus probably 
could be used in this kind of situation. However, the 
efficacy of probiotic in the treatment of antibiotic 
associated diarrhea need to be investigated further.22 
Lactobacillus has few mechanisms of actions: 
Lactobacillus GG has shown beneficial effect in the 
intestinal immunity, increase the number of cells which 
produce immunoglobulin G and other immunoglobulin 
in the intestinal mucosa, and stimulate the release of 
local interferon. This also facilitates the migration of 
antigen in the underlying lymphoid cells and exhibits 
the increase of intake in Peyer patches.21,22
As a conclusion, C. difficile diarrhea is a nosocomial 
diarrhea which occurs in more than 3 days of 
hospitalization with previous exposure to antibiotics. 
The definite diagnosis of C. difficile diarrhea is 
cell culture which shows the cytopathic effect of 
C. difficile toxin. However, with regard to the 
limitation of facilities to perform it, this is difficult 
to do. The diagnosis of C. difficile diarrhea could be 
made base on the supporting symptoms with one of 
the examinations showing the presence of C. difficile 
toxin or supporting endoscopic lesion. The treatment 
of C. difficile diarrhea included rehydration, cease 
the administration of antibiotics, symptomatic, and 
treatment of the complications.  Metronidazole could 
still be used as the first line treatment of C. difficile 
diarrhea. From this case, lesson on the rational use of 
antibiotics was obtained, including always consider 
the indication, contraindication, and adverse effects. 
In addition, policy of antibiotics administration in 
hospital needs to be made to prevent the occurrence 
of nosocomial infection.23-25
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